Discovery of Small Molecules as Membrane-Bound Catechol-<i>O</i>-methyltransferase Inhibitors with Interest in Parkinson's Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies
A pharmacophore-based virtual screening methodology was used to discover new catechol-<i>O</i>-methyltransferase (COMT) inhibitors with interest in Parkinson's disease therapy. To do so, pharmacophore models were constructed using the structure of known inhibitors and then they were...
Saved in:
Main Authors: | Pedro Cruz-Vicente (Author), Ana M. Gonçalves (Author), Octávio Ferreira (Author), João A. Queiroz (Author), Samuel Silvestre (Author), Luís A. Passarinha (Author), Eugenia Gallardo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications
by: Fang-Yuan Wang, et al.
Published: (2021) -
Characterization of NF-kB-mediated inhibition of catechol-<it>O</it>-methyltransferase
by: Conrad Matthew, et al.
Published: (2009) -
Serotonin-Induced Hypersensitivity via Inhibition of Catechol O-Methyltransferase Activity
by: Tsao Douglas, et al.
Published: (2012) -
VAL158MET catechol O-methyltransferase polymorphism contributes to the development of preeclampsia
by: Tamara Sljivancanin Jakovljevic, et al.
Published: (2020) -
Association of catechol-O-methyltransferase gene polymorphisms with treatment response and levodopa-induced complications in Parkinson's disease: A summary of current knowledge
by: Radojević Branislava S., et al.
Published: (2024)